![]() |
市場調查報告書
商品編碼
1388279
內視鏡黏膜下剝離市場 - 按產品(刀、胃鏡和結腸鏡、注射劑、抓握器/夾子、組織牽開器)、按應用(胃、結腸、食道)、按最終用途(醫院、ASC) - 全球預測,2023年- 2032Endoscopic Submucosal Dissection Market - By Product (Knives, Gastroscopes & Colonoscopes, Injection Agents, Graspers/Clips, Tissue Retractors), By Application (Stomach, Colon, Esophageal), By End-use (Hospitals, ASCs) - Global Forecast, 2023-2032 |
由於全球胃癌盛行率不斷上升,內視鏡黏膜下剝離術市場規模預計從 2023 年到 2032 年將以 6.3% 的CAGR擴大。最近,一些國家,特別是亞洲和美洲的胃癌盛行率不斷上升,進一步推動了對內視鏡黏膜下剝離術(ESD)作為重要治療方式的需求。根據美國癌症協會對 2022 年的估計,胃癌占美國每年所有新病例的 1.5%。由於 ESD 能夠精確定位和消除早期胃腫瘤,同時保留器官功能,因此它也成為一種高度首選的治療選擇。
此外,具有更好成像能力的創新內視鏡工具以及具有增強 ESD 手術有效性和安全性的精密儀器的推出將有助於市場擴張。例如,2023 年 1 月,富士軟片印度公司宣布推出 ClutchCutter 和 FushKnife,協助臨床醫生在消化道內進行有效的內視鏡黏膜下剝離術介入。
內視鏡黏膜下剝離術產業分為產品、應用、最終用途和地區。
根據產品,胃鏡和大腸鏡領域的市場佔有率預計從 2023 年到 2032 年將達到 6.2% 的CAGR。胃鏡和大腸鏡設備對胃腸道疾病進行微創手術的需求量很大,因為它們在 ESD 手術期間提供高解析度成像和精確控制,以獲得更好的診斷和治療結果。此外,全球醫療保健系統對早期檢測和介入的日益重視將推動該細分市場的成長。
根據應用,到 2032 年,食道癌領域的內視鏡黏膜下剝離產業預計CAGR為5.9%。針對食道病變和早期癌症的ESD 手術由於其微創性質和保留器官的能力而變得越來越普遍功能。人們對食道疾病的廣泛認知和診斷能力的提高也大大增加了對食道應用量身定做的複雜內視鏡工具的需求。
從地區來看,由於胃腸道疾病盛行率上升以及對微創手術的日益關注,亞太地區內視鏡黏膜下剝離術產業預計在2023年至2032年間呈現7.2%的成長率。由於胃癌發生率高,日本和韓國等國家正努力建立ESD實踐。此外,醫療保健基礎設施的不斷進步、患者意識的提高以及人口老化的加劇將增強行業前景。
Endoscopic Submucosal Dissection Market size is estimated to expand at 6.3% CAGR from 2023-2032, driven by the increasing prevalence of gastric cancer globally. Of late, several nations, particularly in Asia and America are recording elevated rates of gastric cancer prevalence, further driving the demand for endoscopic submucosal dissection (ESD) as a vital treatment modality. According to the American Cancer Society's estimates for 2022, stomach cancer accounts for 1.5% of all new cases in the U.S. each year. ESD has also emerged as a highly preferred treatment option given its ability to precisely target and eliminate early-stage gastric tumors while preserving organ function.
Moreover, the introduction of innovative endoscopic tools with better imaging capabilities, and precision instruments with enhanced effectiveness and safety of ESD procedures will contribute to the market expansion. For instance, in January 2023, FUJIFILM India, announced the launch of ClutchCutter and FushKnife to assist aid clinicians in performing effective endoscopic submucosal dissection interventions within the digestive tract.
The endoscopic submucosal dissection industry is segmented into product, application, end-use, and region.
Based on product, the market share from the gastroscopes and colonoscopes segment is expected to attain 6.2% CAGR from 2023-2032. Gastroscopes and colonoscope devices are recording high demand to perform minimally invasive procedures for gastrointestinal disorders as they provide high-resolution imaging and precise control during ESD procedures for better diagnostic and therapeutic outcomes. Furthermore, the increasing emphasis on early detection and intervention by healthcare systems globally will propel the segment growth.
As per application, the endoscopic submucosal dissection industry from the esophageal cancer segment is estimated to depict 5.9% CAGR through 2032. ESD procedures for esophageal lesions and early-stage cancers have become increasingly prevalent due to their minimally invasive nature and the ability to preserve organ function. The widespread awareness of esophageal disorders and improving diagnostic capabilities is also surging the demand for sophisticated endoscopic tools tailored for esophageal applications.
Regionally, the Asia Pacific endoscopic submucosal dissection industry is poised to exhibit 7.2% growth rate between 2023 and 2032 owing to the rising prevalence of gastrointestinal diseases coupled with the growing focus on minimally invasive procedures. Countries, such as Japan and South Korea are working on establishing ESD practices due to the high incidence of gastric cancer. Moreover, the growing advancements in healthcare infrastructure, increasing patient awareness, and the rising aging population will augment the industry outlook.